GLYCOMIRA
GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.
GLYCOMIRA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.glycomira.com
Total Employee:
1+
Status:
Active
Contact:
1-801-649-3999
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Google Apps For Business Google Maps GoDaddy DNS WordPress 6.0
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Current Employees Featured
Official Site Inspections
http://www.glycomira.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "GlycoMira"
GlycoMira - Crunchbase Company Profile & Funding
Organization. GlycoMira . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... GlycoMira is located in Salt Lake City, Utah, United States. Who …See details»
Investors | GlycoMira.com
1 As of 2024, the criteria for an individual to be considered an accredited investor include: Income Requirement: An individual must have an annual income exceeding $200,000 (or $300,000 …See details»
Team | GlycoMira.com
Dr. Savage has been directing operations at GlycoMira for the past 12 years. Prior to joining the GlycoMira team, Dr. Savage worked at Prolexys Pharmaceuticals where he was instrumental in the preparation of the …See details»
William P. Tew - Chief Executive Officer & Chairman of the
Chief Executive Officer at GlycoMira Therapeutics, Inc. · Entrepreneurial Executive with extensive experience in life science, biopharmaceuticals, and university technology licensing. Proven ...See details»
GlycoMira Company Profile - Office Locations, Competitors ... - Craft
GlycoMira is a biotechnology company developing drug candidates against inflammatory diseases. It offers synthetic glycosaminoglycan-based therapeutics that modulate innate …See details»
GLYCOMIRA THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GLYCOMIRA THERAPEUTICS, INC. of Salt Lake City, UT. Get the latest business insights from Dun & …See details»
GlycoMira - Contacts, Employees, Board Members, Advisors
GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.See details»
GLYCOMIRA, LLC - VentureRadar
GlycoMira is developing an effective treatment for chronic rhinosinusitis, a debilitating inflammatory disease that substantially diminishes the quality of life and productivity of up to …See details»
GlycoMira - Products, Competitors, Financials, Employees, …
GlycoMira is a preclinical-stage biopharmaceutical company focused on developing a new class of innate immune system modulators for the healthcare sector. Use the CB Insights Platform …See details»
Legal Notice | GlycoMira.com
Sub-recipient organization will certify that it has a PHS FCOI compliant policy in place or that it intends to have one in place at the time of the award or that it will abide by GlycoMira’s policy. …See details»
GLYCOMIRA, LLC | SBIR.gov
PROJECT SUMMARYThe goal of this proposal is to optimize and clinically validate a new diagnostic test for eosinophilic chronic rhinosinusitis (eCRS) at the point-of-care, improving the …See details»
Award | SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock (A locked ... the data suggest that GM …See details»
GLYCOMIRA, LLC Company Profile | Dover, DE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GLYCOMIRA, LLC of Dover, DE. Get the latest business insights from Dun & Bradstreet.See details»
Award - SBIR
GlycoMira is developing semi-synthetic glycosaminoglycan ethers (SAGEs) as safe and effective inflammation-modulating inhibitors of RAGE. Specifically, in this Phase I SBIR project, we will …See details»
Technology | GlycoMira.com
Most therapeutic strategies for oncology target key molecules involved in the late stages of disease progression and are not mechanistically based on the recent understanding of …See details»
GLYCOMIRA, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GLYCOMIRA, LLC of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»
Award - SBIR
GlycoMira has developed a family of polyanionic, metabolically stabilized polysaccharides, the semi- synthetic glycosaminoglycan ethers (SAGEs). These new drugs have broad anti …See details»
GlycoMira Press Release 20211026 | GlycoMira.com
Oct 26, 2021 GlycoMira Therapeutics is a privately owned Salt Lake City based biopharmaceutical company focused on the pre-clinical development of innovative anti …See details»
Supportive Care | GlycoMira.com
GlycoMira Therapeutics, Inc. 675 Arapeen Dr. Suite 302 . Salt Lake City UT 84108 ...See details»